Understanding the Costs and Benefits of Investing in Laboratory Systems in African Countries
This policy paper, published by the Center for Global Development, qualitatively establishes the complex costs and benefits of strengthening laboratory capacity and systems within
Quality Control and EQA Strategies for Quality COVID-19 Test Results.
Laboratories need to conduct verification or validation studies to confirm that new tests for COVID-19 diagnosis perform as intended. In this document co-authored by ASLM, FIND and
Integrated Testing for TB and HIV Using GeneXpert Devices Expands Access to near Point-Of-Care Testing
With limited funding for global health, identifying practical, cost and time-saving solutions, while also ensuring quality of care is increasingly important. One approach to increa
Accelerating Access to Point-of-Care Viral Load Testing for Pregnant and Breastfeeding Women Living with HIV
Increased access to antiretroviral therapy (ART) and treatment monitoring for pregnant and breastfeeding women living with HIV is a priority for promoting health during the pregnan
HIV Molecular Diagnostics Toolkit to Improve Access to Viral Load Testing and Infant Diagnosis
Currently, about half of patients on antiretroviral treatment have access to viral load testing; however, access remains focused within a small number of countries. To date, routin
Point-of-care testing as a solution for timely early infant diagnosis
Based on the recent encouraging evidence POC/ near-POC EID warrants consideration of rapid adoption and strategic scale up of this solution complementing the existing laborat